-
Rituximab and COVID-19 Vaccine Response in Autoimmune Diseases
Rituximab is being prescribed for some Lambert-Eaton patients ‘off-label’ just like it is for other autoimmune disorders like multiple sclerosis. We’re well along with getting COVID-19 vaccinations, most of us get one or more additional boosters. The lingering question is: How effective are the vaccine shots when given to LEMS patients on Rituximab?
Rituximab is an immunotherapy treatment. Here’s a fact sheet about it from the Mayo Clinic, HERE.
Because the LEMS patient population is so small, we aren’t going to get big studies on the question postulated above. But, there has been one done for multiple sclerosis patients on Rituximab. It should be an interesting read for those LEMS patients on the treatment. I think it is illuminating and attempts to get at the answer of the COVID-19 vaccine effectiveness when on an immunosuppressant.
You can read the article, “With Rituximab, B-cell Counts Predict COVID-19 Vaccine Response”, HERE, from the Multiple Sclerosis News Today website.
If you’re on Rituximab infusions, how have you handled getting your vaccinations? We’d like to hear from you!
Log in to reply.